Core Viewpoint - Bath & Body Works, Inc. is facing a class action lawsuit due to alleged misleading statements regarding its growth strategy and financial performance during the specified class period from June 4, 2024, to November 19, 2025 [1] Company Overview - Bath & Body Works is a specialty retailer focused on home fragrance and body care products, and during the relevant period, it explored product categories beyond its core business, including men's products, lip care, hair care, and laundry items [3] Financial Performance - On August 28, 2025, Bath & Body Works reported disappointing Q2 2025 results, cutting its full-year earnings guidance by $0.03 to a range of $3.28 to $3.53 per diluted share, which led to a stock price drop of $2.18, or 6.9%, from $31.54 to $29.36 [5] - Following the Q3 2025 results released on November 20, 2025, the company announced further cuts to its full-year guidance and acknowledged that its strategy of pursuing adjacencies had not grown its total customer base, resulting in a stock price decline of $5.22, or 24.8%, from $21.04 to $15.82 [6] Strategic Misalignment - Bath & Body Works claimed that customers were responding favorably to its innovation and adjacencies, asserting that its strategy was effective in driving topline growth; however, it was alleged that the strategy did not deliver the expected growth in net sales or expand the customer base [4]
Portnoy Law Firm Announces Class Action on Behalf of Bath & Body Works, Inc.. Investors